Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Promising combination therapies with gemcitabine.
Robinson BW, Ostruszka L, Im MM, Shewach DS. Robinson BW, et al. Semin Oncol. 2004 Apr;31(2 Suppl 5):2-12. doi: 10.1053/j.seminoncol.2004.03.021. Semin Oncol. 2004. PMID: 15199526
Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
Eisbruch A, Shewach DS, Bradford CR, Littles JF, Teknos TN, Chepeha DB, Marentette LJ, Terrell JE, Hogikyan ND, Dawson LA, Urba S, Wolf GT, Lawrence TS. Eisbruch A, et al. Among authors: shewach ds. J Clin Oncol. 2001 Feb 1;19(3):792-9. doi: 10.1200/JCO.2001.19.3.792. J Clin Oncol. 2001. PMID: 11157033 Clinical Trial.
Antimetabolite radiosensitizers.
Shewach DS, Lawrence TS. Shewach DS, et al. J Clin Oncol. 2007 Sep 10;25(26):4043-50. doi: 10.1200/JCO.2007.11.5287. J Clin Oncol. 2007. PMID: 17827452 Review.
Radiosensitization by gemcitabine.
Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS. Lawrence TS, et al. Among authors: shewach ds. Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):55-60. Oncology (Williston Park). 1999. PMID: 10550827 Free article. Review.
95 results